• Mortality in Multiple Sclerosis 3 times higher, we know. But the cause of death is surprising…

    New study found that mortality and comorbidities are higher in Multiple Sclerosis patients than in the average population. The study was funded by Novartis Pharma AG, Basel, Switzerland.

     

    Highlights

    Mortality and comorbidity data are limited for patients with MS

    Mortality was 2.9-fold higher in the MS cohort versus the non-MS cohort

    Several comorbidities were higher in the MS versus non-MS cohort

    Focused monitoring of MS may permit intervention to reduce comorbidities/mortality

     

    Leading cause of death in Multiple Sclerosis

    Infectious diseases, sepsis

     

    Frequent comorbidities in Multiple Sclerosis

    Infectious diseases, sepsis

    Diseases of the nervous system

    Diseases of the respiratory system

    Diseases of the circulatory system

    Attempted suicide, suicide

    Ischemic stroke

    Ulcerative colitis

    Cancer

     

    Conclusion

    The researchers came to the following conclusions “Early recognition and management of comorbidities may reduce premature mortality and improve quality of life in patients with MS.”

    Leave a reply →
Book an Appointment.